Tianjin Cross-Strait Biotechnology Development Co., Ltd.
Tianjin Liang'an Biological Technology Development Co., Ltd. was developed and constructed by the 100-year-old group and undertaken by Zhongtian Construction Group Co., Ltd. The project is developed in four phases, with a total planned area of 1.5 million square meters, and the first phase of the project is 300,000 square meters, divided into A / B. The plot, plot A, covers an area of 10,1188.8 square meters, with a total construction area of 152551.93 square meters and a greening rate of 20%. A total of 34 buildings, including 33 factories and an industrial building, will be completed in October 2020, featuring biotechnology features.
After the project is completed, a number of well-known cross-strait biotechnology companies such as Taiwan Golden Diamond International Co., Ltd., Taiwan Wangbao Biotechnology Co., Ltd., Beijing Jianping Jiuxing Biopharmaceutical Technology Co., Ltd., and Shenyang Baisui Biotechnology Development Co., Ltd. will settle in. The project also absorbs traditional industries: biomedicine, electronic information, high-end equipment manufacturing, precision instrumentation; emerging industries: modern medical health, robotics, big data, the Internet, CNC machine tools and other industries.
